spacer
Topic quick links:
Cover page
spacer
All articles in this issue:
New report reveals the latest drug trends in Europe
EMCDDA select new director
Ireland's national suicide strategy 2015-2010, and the evidence base
IMO targets addiction and dependency
CityWide starts debate ahead of UNGASS 2016
Towards UNGASS 2016
Judging prohibition
Misuse of Drugs Amendment) Act 2015
National Drugs Strategy (NDS) 2009-2016: progress in 2014
Benzodiazepine use among young people attending a treatment centre
Treated problem alcohol use in Ireland, NDTRS data 2013
Changes to the NDTRS form for 2016 data collection
Nursing in contexts of marginalised health
Predicting retention in MMT in Ireland
Low-threshold residential stabilisation service (LTRSS) in Ireland
Needle exchange provision in Ireland in 2012
Releasing prisoners early - Community Return
EMCDDA update
Recent publications
Upcoming events



Benzodiazepine use among young people attending a treatment centre
by Suzi Lyons


Benzodiazepines are commonly-prescribed drugs used for a wide range of conditions and symptoms including anxiety, insomnia and epilepsy.  They have short-term side-effects, e.g. impairment of perception of risk, restlessness, agitation, anxiety and delusions, and long-term use can lead to dependence.  The 2010/2011 National Drug Prevalence Survey found that lifetime use of benzodiazepines among 15–34-year-olds in Ireland was 35.7%, an increase on lifetime use at the time of the previous survey.1


Full Story »



Treated problem alcohol use in Ireland, NDTRS data 2013
by Suzi Lyons


The most recent figures on treated problem alcohol use from the National Drug Treatment Reporting System (NDTRS) show that a total of 7,549 cases were treated for problem alcohol use in 2013, a drop of 12.3% since 2011.


Full Story »
Email Software by Newsweaver